The Effect of Virtual Reality Glasses on Pain Level and Hemo-Dynamic Variables After Open Heart Surgery
Launched by MERSIN UNIVERSITY · Oct 14, 2022
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is investigating how virtual reality (VR) glasses can help reduce pain and improve stability in patients after open heart surgery. The study will take place from January to June 2025 and will involve 82 patients who are in the cardiovascular surgery intensive care unit. To be eligible to participate, patients must be between 18 and 80 years old, speak and understand Turkish, and be on the 2nd or 3rd day after their surgery. They should also be stable, conscious, and cooperative, and have a chest tube without any sensitivity or trauma in the area where the VR glasses will be applied.
If you or a loved one qualifies for this trial, you can expect to wear VR glasses while in the hospital to see if this technology can help make the recovery process more comfortable. Participants will be monitored closely to assess their pain levels and how well their body is responding after surgery. It’s important to know that those with certain health conditions, such as active COVID-19 or specific psychiatric diagnoses, will not be able to join the study.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Agreeing to participate in the research (signing the Informed Consent Form),
- • Conscious and cooperative,
- • Stable hemodynamic status,
- • Speaks and understands Turkish,
- • Over 18 years old,
- • On the 2nd and 3rd day after open heart surgery,
- • Having chest tube,
- • No sensitivity or trauma in the area (for the study group) where the virtual reality glasses will be applied,
- • No active COVID-19 infection,
- • Patients without any psychiatric diagnosis
- Exclusion Criteria:
- • Agreeing to participate in the research (signing the Informed Consent Form),
- • Not conscious,
- • Not cooperative
- • Unstable hemodynamic status,
- • Speaks and understands Turkish,
- • who are under the age of 18,
- • On the 0th or 1st day after surgery,
- • No chest tube,
- • Has sensitivity or trauma in the area (for the study group) where the virtual reality
- • Active COVID-19 infection,
- • Patients with a psychiatric diagnosis
About Mersin University
Mersin University is a distinguished academic institution located in Mersin, Turkey, committed to advancing healthcare through innovative research and clinical trials. With a strong emphasis on interdisciplinary collaboration, the university leverages its extensive resources, expert faculty, and state-of-the-art facilities to facilitate groundbreaking studies. Mersin University aims to contribute to the global medical community by fostering the development of new therapies and improving patient outcomes through rigorous scientific inquiry and ethical standards in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Mersin, Turkey/Mersin,Yenişehir, Turkey
Mersin, , Turkey
Patients applied
Trial Officials
Gülay ALTUN UĞRAŞ, PhD
Principal Investigator
Mersin University
Sevban ARSLAN, PhD
Principal Investigator
Cukurova University
Muaz GÜLŞEN, master
Principal Investigator
Cukurova University
Firdevs Ebru ÖZDEMİR, master
Principal Investigator
Mersin University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials